nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0981	0.28	CbGbCtD
Bicalutamide—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0613	0.175	CbGbCtD
Bicalutamide—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.057	0.163	CbGbCtD
Bicalutamide—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.042	0.12	CbGbCtD
Bicalutamide—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0262	0.0747	CbGbCtD
Bicalutamide—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0257	0.0734	CbGbCtD
Bicalutamide—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.024	0.0684	CbGbCtD
Bicalutamide—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0164	0.0467	CbGbCtD
Bicalutamide—Enzalutamide—ABCB1—peripheral nervous system neoplasm	0.00471	1	CrCbGaD
Bicalutamide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000324	0.000503	CcSEcCtD
Bicalutamide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000324	0.000502	CcSEcCtD
Bicalutamide—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000323	0.0005	CcSEcCtD
Bicalutamide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000323	0.0005	CcSEcCtD
Bicalutamide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000323	0.0005	CcSEcCtD
Bicalutamide—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.0005	CcSEcCtD
Bicalutamide—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000322	0.000499	CcSEcCtD
Bicalutamide—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000321	0.000498	CcSEcCtD
Bicalutamide—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000496	CcSEcCtD
Bicalutamide—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00032	0.000496	CcSEcCtD
Bicalutamide—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000492	CcSEcCtD
Bicalutamide—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000489	CcSEcCtD
Bicalutamide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000315	0.000489	CcSEcCtD
Bicalutamide—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.000487	CcSEcCtD
Bicalutamide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000314	0.000487	CcSEcCtD
Bicalutamide—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000486	CcSEcCtD
Bicalutamide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000312	0.000485	CcSEcCtD
Bicalutamide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000312	0.000484	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000311	0.000483	CcSEcCtD
Bicalutamide—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000479	CcSEcCtD
Bicalutamide—Pain—Cisplatin—peripheral nervous system neoplasm	0.000309	0.000479	CcSEcCtD
Bicalutamide—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000477	CcSEcCtD
Bicalutamide—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000477	CcSEcCtD
Bicalutamide—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000473	CcSEcCtD
Bicalutamide—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000473	CcSEcCtD
Bicalutamide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000304	0.000471	CcSEcCtD
Bicalutamide—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000468	CcSEcCtD
Bicalutamide—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000468	CcSEcCtD
Bicalutamide—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000468	CcSEcCtD
Bicalutamide—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000467	CcSEcCtD
Bicalutamide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000301	0.000466	CcSEcCtD
Bicalutamide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.0003	0.000465	CcSEcCtD
Bicalutamide—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000463	CcSEcCtD
Bicalutamide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000297	0.000461	CcSEcCtD
Bicalutamide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000297	0.00046	CcSEcCtD
Bicalutamide—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000296	0.00046	CcSEcCtD
Bicalutamide—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000457	CcSEcCtD
Bicalutamide—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000295	0.000457	CcSEcCtD
Bicalutamide—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000456	CcSEcCtD
Bicalutamide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000294	0.000456	CcSEcCtD
Bicalutamide—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000456	CcSEcCtD
Bicalutamide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000293	0.000454	CcSEcCtD
Bicalutamide—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000453	CcSEcCtD
Bicalutamide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00029	0.000451	CcSEcCtD
Bicalutamide—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.00045	CcSEcCtD
Bicalutamide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00029	0.00045	CcSEcCtD
Bicalutamide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000288	0.000447	CcSEcCtD
Bicalutamide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000287	0.000446	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000285	0.000443	CcSEcCtD
Bicalutamide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000285	0.000443	CcSEcCtD
Bicalutamide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000285	0.000442	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000442	CcSEcCtD
Bicalutamide—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000439	CcSEcCtD
Bicalutamide—Pain—Etoposide—peripheral nervous system neoplasm	0.000283	0.000439	CcSEcCtD
Bicalutamide—Constipation—Etoposide—peripheral nervous system neoplasm	0.000283	0.000439	CcSEcCtD
Bicalutamide—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000438	CcSEcCtD
Bicalutamide—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000438	CcSEcCtD
Bicalutamide—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000437	CcSEcCtD
Bicalutamide—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000437	CcSEcCtD
Bicalutamide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00028	0.000434	CcSEcCtD
Bicalutamide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000279	0.000433	CcSEcCtD
Bicalutamide—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000432	CcSEcCtD
Bicalutamide—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000432	CcSEcCtD
Bicalutamide—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000277	0.00043	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000426	CcSEcCtD
Bicalutamide—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000426	CcSEcCtD
Bicalutamide—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000425	CcSEcCtD
Bicalutamide—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000423	CcSEcCtD
Bicalutamide—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000423	CcSEcCtD
Bicalutamide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000272	0.000423	CcSEcCtD
Bicalutamide—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000422	CcSEcCtD
Bicalutamide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000271	0.000421	CcSEcCtD
Bicalutamide—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000419	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00027	0.000419	CcSEcCtD
Bicalutamide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00027	0.000419	CcSEcCtD
Bicalutamide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000269	0.000418	CcSEcCtD
Bicalutamide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000267	0.000414	CcSEcCtD
Bicalutamide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000267	0.000414	CcSEcCtD
Bicalutamide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000266	0.000412	CcSEcCtD
Bicalutamide—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000412	CcSEcCtD
Bicalutamide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000265	0.000412	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000409	CcSEcCtD
Bicalutamide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000263	0.000407	CcSEcCtD
Bicalutamide—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000407	CcSEcCtD
Bicalutamide—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000407	CcSEcCtD
Bicalutamide—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000406	CcSEcCtD
Bicalutamide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000261	0.000405	CcSEcCtD
Bicalutamide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000261	0.000405	CcSEcCtD
Bicalutamide—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000405	CcSEcCtD
Bicalutamide—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000405	CcSEcCtD
Bicalutamide—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000405	CcSEcCtD
Bicalutamide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000259	0.000403	CcSEcCtD
Bicalutamide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000259	0.000402	CcSEcCtD
Bicalutamide—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000402	CcSEcCtD
Bicalutamide—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.0004	CcSEcCtD
Bicalutamide—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000258	0.0004	CcSEcCtD
Bicalutamide—Rash—Vincristine—peripheral nervous system neoplasm	0.000257	0.000399	CcSEcCtD
Bicalutamide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000257	0.000399	CcSEcCtD
Bicalutamide—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000399	CcSEcCtD
Bicalutamide—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000398	CcSEcCtD
Bicalutamide—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000397	CcSEcCtD
Bicalutamide—Headache—Vincristine—peripheral nervous system neoplasm	0.000256	0.000397	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000394	CcSEcCtD
Bicalutamide—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000393	CcSEcCtD
Bicalutamide—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000391	CcSEcCtD
Bicalutamide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000251	0.00039	CcSEcCtD
Bicalutamide—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000251	0.00039	CcSEcCtD
Bicalutamide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000247	0.000383	CcSEcCtD
Bicalutamide—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000381	CcSEcCtD
Bicalutamide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000244	0.000378	CcSEcCtD
Bicalutamide—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000376	CcSEcCtD
Bicalutamide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000242	0.000376	CcSEcCtD
Bicalutamide—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000376	CcSEcCtD
Bicalutamide—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000375	CcSEcCtD
Bicalutamide—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000374	CcSEcCtD
Bicalutamide—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000372	CcSEcCtD
Bicalutamide—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.00037	CcSEcCtD
Bicalutamide—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000369	CcSEcCtD
Bicalutamide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000237	0.000368	CcSEcCtD
Bicalutamide—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000367	CcSEcCtD
Bicalutamide—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000367	CcSEcCtD
Bicalutamide—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000365	CcSEcCtD
Bicalutamide—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000365	CcSEcCtD
Bicalutamide—Chills—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000363	CcSEcCtD
Bicalutamide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000234	0.000363	CcSEcCtD
Bicalutamide—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000361	CcSEcCtD
Bicalutamide—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000361	CcSEcCtD
Bicalutamide—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000358	CcSEcCtD
Bicalutamide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000229	0.000356	CcSEcCtD
Bicalutamide—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000354	CcSEcCtD
Bicalutamide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000227	0.000353	CcSEcCtD
Bicalutamide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000227	0.000353	CcSEcCtD
Bicalutamide—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000352	CcSEcCtD
Bicalutamide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000226	0.000351	CcSEcCtD
Bicalutamide—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000347	CcSEcCtD
Bicalutamide—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000347	CcSEcCtD
Bicalutamide—Tension—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000346	CcSEcCtD
Bicalutamide—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000342	CcSEcCtD
Bicalutamide—Back pain—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000341	CcSEcCtD
Bicalutamide—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.00034	CcSEcCtD
Bicalutamide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000219	0.000339	CcSEcCtD
Bicalutamide—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000339	CcSEcCtD
Bicalutamide—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000338	CcSEcCtD
Bicalutamide—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000337	CcSEcCtD
Bicalutamide—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000336	CcSEcCtD
Bicalutamide—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000334	CcSEcCtD
Bicalutamide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000214	0.000332	CcSEcCtD
Bicalutamide—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000331	CcSEcCtD
Bicalutamide—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000328	CcSEcCtD
Bicalutamide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00021	0.000326	CcSEcCtD
Bicalutamide—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000326	CcSEcCtD
Bicalutamide—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000326	CcSEcCtD
Bicalutamide—Rash—Etoposide—peripheral nervous system neoplasm	0.000208	0.000323	CcSEcCtD
Bicalutamide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000208	0.000323	CcSEcCtD
Bicalutamide—Headache—Etoposide—peripheral nervous system neoplasm	0.000207	0.000321	CcSEcCtD
Bicalutamide—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000321	CcSEcCtD
Bicalutamide—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.00032	CcSEcCtD
Bicalutamide—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000317	CcSEcCtD
Bicalutamide—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000316	CcSEcCtD
Bicalutamide—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000315	CcSEcCtD
Bicalutamide—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000313	CcSEcCtD
Bicalutamide—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.0002	0.00031	CcSEcCtD
Bicalutamide—Cough—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000307	CcSEcCtD
Bicalutamide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000196	0.000305	CcSEcCtD
Bicalutamide—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000304	CcSEcCtD
Bicalutamide—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000301	CcSEcCtD
Bicalutamide—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000193	0.0003	CcSEcCtD
Bicalutamide—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000193	0.0003	CcSEcCtD
Bicalutamide—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000299	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000298	CcSEcCtD
Bicalutamide—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000293	CcSEcCtD
Bicalutamide—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000292	CcSEcCtD
Bicalutamide—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000187	0.00029	CcSEcCtD
Bicalutamide—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000287	CcSEcCtD
Bicalutamide—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000286	CcSEcCtD
Bicalutamide—Infection—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000286	CcSEcCtD
Bicalutamide—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000284	CcSEcCtD
Bicalutamide—Shock—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000283	CcSEcCtD
Bicalutamide—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000282	CcSEcCtD
Bicalutamide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000281	CcSEcCtD
Bicalutamide—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000281	CcSEcCtD
Bicalutamide—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000279	CcSEcCtD
Bicalutamide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000278	CcSEcCtD
Bicalutamide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000277	CcSEcCtD
Bicalutamide—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000277	CcSEcCtD
Bicalutamide—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000276	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000276	CcSEcCtD
Bicalutamide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000274	CcSEcCtD
Bicalutamide—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000271	CcSEcCtD
Bicalutamide—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000268	CcSEcCtD
Bicalutamide—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000266	CcSEcCtD
Bicalutamide—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000264	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000262	CcSEcCtD
Bicalutamide—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000262	CcSEcCtD
Bicalutamide—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000261	CcSEcCtD
Bicalutamide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.00026	CcSEcCtD
Bicalutamide—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000168	0.00026	CcSEcCtD
Bicalutamide—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000258	CcSEcCtD
Bicalutamide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000258	CcSEcCtD
Bicalutamide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000257	CcSEcCtD
Bicalutamide—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000256	CcSEcCtD
Bicalutamide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000256	CcSEcCtD
Bicalutamide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000254	CcSEcCtD
Bicalutamide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000253	CcSEcCtD
Bicalutamide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000161	0.00025	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000248	CcSEcCtD
Bicalutamide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000248	CcSEcCtD
Bicalutamide—Pain—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000246	CcSEcCtD
Bicalutamide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000246	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000242	CcSEcCtD
Bicalutamide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000241	CcSEcCtD
Bicalutamide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000239	CcSEcCtD
Bicalutamide—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000237	CcSEcCtD
Bicalutamide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000237	CcSEcCtD
Bicalutamide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000236	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000235	CcSEcCtD
Bicalutamide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000234	CcSEcCtD
Bicalutamide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000231	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00023	CcSEcCtD
Bicalutamide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000229	CcSEcCtD
Bicalutamide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000228	CcSEcCtD
Bicalutamide—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000227	CcSEcCtD
Bicalutamide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000227	CcSEcCtD
Bicalutamide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000227	CcSEcCtD
Bicalutamide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000227	CcSEcCtD
Bicalutamide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000219	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000217	CcSEcCtD
Bicalutamide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000212	CcSEcCtD
Bicalutamide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000211	CcSEcCtD
Bicalutamide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.00021	CcSEcCtD
Bicalutamide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.00021	CcSEcCtD
Bicalutamide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000206	CcSEcCtD
Bicalutamide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000203	CcSEcCtD
Bicalutamide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000197	CcSEcCtD
Bicalutamide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000196	CcSEcCtD
Bicalutamide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000191	CcSEcCtD
Bicalutamide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000123	0.00019	CcSEcCtD
Bicalutamide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000188	CcSEcCtD
Bicalutamide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000183	CcSEcCtD
Bicalutamide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000182	CcSEcCtD
Bicalutamide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000181	CcSEcCtD
Bicalutamide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000181	CcSEcCtD
Bicalutamide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000116	0.00018	CcSEcCtD
Bicalutamide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000176	CcSEcCtD
Bicalutamide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000171	CcSEcCtD
Bicalutamide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000169	CcSEcCtD
Bicalutamide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000168	CcSEcCtD
Bicalutamide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000168	CcSEcCtD
Bicalutamide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000167	CcSEcCtD
Bicalutamide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000158	CcSEcCtD
